1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2022HIGH EXPRESSION OF VACUOLAR-ATPASE SUBUNIT ATP6V1B1 PROMOTES POOR PROGNOSIS AND TUMORIGENIC CHARACTERISTICS IN EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF TRAFFICKING PROTEIN TRANSMEMBRANE P24 TRAFFICKING PROTEIN9 PROMOTES POOR PROGNOSIS OF EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF PHOSPHODIESTERASE 1 (PDE1A) PROMOTES POOR PROGNOSIS AND ASSOCIATED WITH PLATINUM BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Genomic DNA analysis of cervical smear samples of endometrial cancer with next-generation sequencing: A prospective studyANNALS OF ONCOLOGY
2022Feasibility of longitudinal monitoring of whole blood-based circulating tumour DNA (ctDNA) in patients with endometrial cancerANNALS OF ONCOLOGY
2022Expression profiles of id and E2A in ovarian cancer and sup-pression of ovarian cancer by the E2A isoform E47INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Efficacy and safety of GX-188E, a therapeutic DNA vaccine, combined with pembrolizumab in HPV 16- and/or 18- positive advanced cervical cancer (phase II): Safe and effective in both PD-L1 positive and negativeANNALS OF ONCOLOGY
2022Dynamic changes of peripheral regulatory t cells during parp inhibitor maintenance therapy in patients with ovarian cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trialINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Clinical relevance of red blood cell distribution as prognostic marker in endometrial carcinomaINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Clinical outcomes of BRCA1/2 pathogenic variants in ovarian cancer cluster region in patients with primary peritoneal, epithelial ovarian, and fallopian tube cancerGYNECOLOGIC ONCOLOGY
2022An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive recurrent cervical cancer INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Added value of sentinel lymph node biopsy in patients with negative lymph node on triple pre-operative imagesINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2023Chromosomal Abnormality, fetal/neonatal Death and Socioeconomic Status: A Prospective Cohort StudyMATERNAL AND CHILD HEALTH JOURNAL
2023High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer ONCOLOGY REPORTS
2023Differential Expression of NME4 in Trophoblast Stem-Like Cells and Peripheral Blood Mononuclear Cells of Normal Pregnancy and Preeclampsia JOURNAL OF KOREAN MEDICAL SCIENCE
2023HOXA‑AS3 induces tumor progression through the epithelial‑mesenchymal transition pathway in epithelial ovarian cancer ONCOLOGY REPORTS
2023Clinical Relevance of Uterine Manipulation on Oncologic Outcome in Robot-Assisted versus Open Surgery in the Management of Endometrial CancerJOURNAL OF CLINICAL MEDICINE

Recent Submissions

Browse

Links